Market Access

In Government Affairs & Patient Advocacy, we work to ensure that the people who need our products and services can get them and ensure that societies and insurance institutions prioritise a willingness to fund personalised intimate care for people with a chronic condition. This means having dialogues with a number of different external stakeholders – patient groups, payers, government agencies, industry associations, and healthcare practitioners, among others – to raise disease awareness and highlight unmet patient needs. We engage in complex issues like new life science regulations, healthcare reforms, reimbursement & procurement systems to ensure that countries have the right health policy and payment frameworks in place for our products and services to be accessible and affordable for patients. In close cooperation with our subsidiaries, we drive health & life science advocacy by preparing value stories, facilitating delegation visits and engaging in partnerships.